GPC3-Targeted PET/CT in Hepatocellular Carcinoma
8d agoen
From the article
Conditions : Hepatocellular Carcinoma (HCC); Glypican-3; GPC3-targeted PET/CT Interventions : Diagnostic Test: 18F-FDG PET/CT and GPC3-targeted PET/CT Sponsors : The First Affiliated Hospital of Xiamen University Recruiting
Continue reading on clinicaltrials.govYou might also wanna read
Development of LRRC15-binding disulfide-constrained peptides for PET imaging of cancer-associated fibroblasts
doi.org·15h ago
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Nature Communications·8d ago

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from
cell.com·13d ago
Phase 3 trial: PSMA-PET-CT may help some high-risk men avoid prostate biopsy
A phase 3 clinical trial published in The Lancet Oncology suggests that PSMA-PET-CT imaging may help determine which men at high clinical ri
Machine Learning Model Shows Promise for Predicting Liver Cancer Risk in Young Adults
Researchers developed and validated machine learning models to predict early-onset hepatocellular carcinoma (HCC) risk in young adults using
Silent Threat: Fatty Liver Disease Linked to Cancer, Dementia Risk
ltcnews.com·2y ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.